All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health’s Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Continuation of treatment with blinded doses of crofelemer in the extension phase of the trial will support company's plans to...